MedPage Today on MSN
ADC Post-Endocrine Therapy Misses Mark in Advanced Breast Cancer Trial
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first ...
Sacituzumab does not improve outcomes vs chemotherapy when used as the first treatment after endocrine therapy failure in HR+/HER2- advanced breast cancer, the ASCENT-07 trial finds.
Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...
Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following ...
Candy graduated from Mount Sinai’s nursing program at City College of New York and by 1975 was working in the neonatal unit ...
Progression-free response stayed consistent across age, BMI, and menopausal status in MONALEESA pooled analysis1 KISQALI is only CDK4/6i to demonstrate statistically significant overall survival (OS) ...
Eric Dane, who played Dr. Mark Sloan, aka “McSteamy,” on “Grey’s Anatomy” for six seasons, is returning to TV on another medical drama. The actor, 53, makes his “Brilliant Minds” debut as “Bronx-Gen’s ...
Who says you can’t go home again? In the world of Grey’s Anatomy, not even death can keep characters from returning to the ...
Media seeking NAPT materials can access assets here.
The Center for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) voted 8-3 to drop ...
To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...
Based on a list compiled by the American Institute of Physics, UNG had 19 physics graduates in 2023-24. As impressive as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results